Michelle Vanase‐Frawley

844 total citations
19 papers, 515 citations indexed

About

Michelle Vanase‐Frawley is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Michelle Vanase‐Frawley has authored 19 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in Michelle Vanase‐Frawley's work include Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Michelle Vanase‐Frawley is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Michelle Vanase‐Frawley collaborates with scholars based in United States and Spain. Michelle Vanase‐Frawley's co-authors include Anne W. Schmidt, Patrick R. Verhoest, Aarti Sawant‐Basak, Spiros Liras, Kari R. Fonseca, Stafford McLean, Sarah Grimwood, Xinjun Hou, Simone Sciabola and Emily Miller and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michelle Vanase‐Frawley

19 papers receiving 505 citations

Peers

Countries citing papers authored by Michelle Vanase‐Frawley

Since Specialization

Citations

This map shows the geographic impact of Michelle Vanase‐Frawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Vanase‐Frawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Vanase‐Frawley more than expected).

Fields of papers citing papers by Michelle Vanase‐Frawley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Vanase‐Frawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Vanase‐Frawley. The network helps show where Michelle Vanase‐Frawley may publish in the future.

Co-authorship network of co-authors of Michelle Vanase‐Frawley

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Vanase‐Frawley. A scholar is included among the top collaborators of Michelle Vanase‐Frawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Vanase‐Frawley. Michelle Vanase‐Frawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs 2018 ·Scientific Reports ·Noelia Ferruz, Stefan Doerr, Michelle Vanase‐Frawley, Yaozhong Zou, Xiaohong Chen, Eric S. Marr, (unknown), Bethany L. Kormos, Travis T. Wager, Xinjun Hou, Anabella Villalobos, Simone Sciabola, Gianni De Fabritiis	44
2	Hybrid peptide-small molecule oxytocin analogs are potent and selective agonists of the oxytocin receptor 2017 ·Bioorganic & Medicinal Chemistry Letters ·Natasha M. Kablaoui, Michelle Vanase‐Frawley, Simone Sciabola	8
3	Systematic N-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network 2016 ·Bioorganic & Medicinal Chemistry ·Simone Sciabola, Gilles H. Goetz, Guoyun Bai, Bruce N. Rogers, David Gray, Allen J. Duplantier, Kari R. Fonseca, Michelle Vanase‐Frawley, Natasha M. Kablaoui	23
4	Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing 2016 ·Journal of Pharmacology and Experimental Therapeutics ·Meera E. Modi, Mark J. Majchrzak, Kari R. Fonseca, Angela C. Doran, Sharon Osgood, Michelle Vanase‐Frawley, Eric Feyfant, (unknown), (unknown), Derek L. Buhl, Natasha M. Kablaoui	24
5	Strategies toward optimization of the metabolism of a series of serotonin-4 partial agonists: investigation of azetidines as piperidine isosteres 2016 ·Xenobiotica ·R. Scott Obach, Erik LaChapelle, Michael A. Brodney, Michelle Vanase‐Frawley, Gregory W. Kauffman, Aarti Sawant‐Basak	9
6	Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects 2016 ·ACS Chemical Neuroscience ·Travis T. Wager, Thomas A. Chappie, (unknown), Ramalakshmi Y. Chandrasekaran, Brian Samas, (unknown), Cathleen C. Hsu, Nawshaba Nawreen, Michelle Vanase‐Frawley, Rebecca E. O’Connor, Christopher J. Schmidt, (unknown), Nancy C. Stratman, Mark J. Majchrzak, Bethany L. Kormos, David P. Nguyen, Aarti Sawant‐Basak, Andy Mead	21
7	Design, synthesis and evaluation of [3H]PF-7191, a highly specific nociceptin opioid peptide (NOP) receptor radiotracer for in vivo receptor occupancy (RO) studies 2014 ·Bioorganic & Medicinal Chemistry Letters ·Lei Zhang, (unknown), Michael A. Brodney, Julie Cianfrogna, Susan E. Drozda, Sarah Grimwood, Michelle Vanase‐Frawley, Anabella Villalobos	15
8	Metabolism of a Serotonin-4 Receptor Partial Agonist 4-{4-[4-Tetrahydrofuran-3-yloxy)-Benzo[d]Isoxazol-3-yloxymethyl]-Piperidin-1-ylmethyl}-Tetrahydropyran-4-ol (TBPT): Identification of an Unusual Pharmacologically Active Cyclized Oxazolidine Metabolite in Human 2013 ·Journal of Pharmaceutical Sciences ·Aarti Sawant‐Basak, Karen J. Coffman, Gregory S. Walker, Tim F. Ryder, Elaine Tseng, Emily Miller, (unknown), Michelle Vanase‐Frawley, John W. Wong, Michael A. Brodney, (unknown), R. Scott Obach	12
9	The 5-Hydroxytryptamine4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ Oscillations 2012 ·Journal of Pharmacology and Experimental Therapeutics ·David E. Johnson, (unknown), Sarah Grimwood, Aarti Sawant‐Basak, Emily Miller, Elaine Tseng, Laura McDowell, Michelle Vanase‐Frawley, Katherine Fisher, David M. Rubitski, K J Stutzman-Engwall, (unknown), W. Elliott Horner, (unknown), Mihály Hajós, Chester J. Siok	47
10	Design and Discovery of 6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders 2012 ·Journal of Medicinal Chemistry ·Patrick R. Verhoest, Kari R. Fonseca, Xinjun Hou, (unknown), Michael L. Corman, Christopher J. Helal, Michelle M. Claffey, Jamison B. Tuttle, Karen J. Coffman, (unknown), Frederick Nelson, Robin J. Kleiman, Frank S. Menniti, Christopher J. Schmidt, Michelle Vanase‐Frawley, Spiros Liras	53
11	Identification of Multiple 5-HT₄Partial Agonist Clinical Candidates for the Treatment of Alzheimer’s Disease 2012 ·Journal of Medicinal Chemistry ·Michael A. Brodney, David E. Johnson, Aarti Sawant‐Basak, Karen J. Coffman, (unknown), (unknown), Katherine Fisher, (unknown), Nobuaki Waizumi, Laura McDowell, Αλέξανδρος Παπανικολάου, Betty Pettersen, Anne W. Schmidt, Elaine Tseng, K J Stutzman-Engwall, David M. Rubitski, Michelle Vanase‐Frawley, Sarah Grimwood	36
12	Pharmacological Characterization of 2-Methyl-N-((2′-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a High-Affinity Antagonist Selective for κ-Opioid Receptors 2011 ·Journal of Pharmacology and Experimental Therapeutics ·S. Grimwood, Yang Lü, Anne W. Schmidt, Michelle Vanase‐Frawley, Aarti Sawant‐Basak, Emily Miller, Stafford McLean, John Freeman, Stephen T.C. Wong, Jay P. McLaughlin, Patrick R. Verhoest	52
13	Discovery of CP-866,087, a mu opioid receptor antagonist for the treatment of alcohol abuse and dependence 2011 ·MedChemComm ·Stanton F. McHardy, Steven D. Heck, Sara Guediche, (unknown), Martin P. Allen, Meihua Tu, Dianne K. Bryce, Anne W. Schmidt, Michelle Vanase‐Frawley, Ernesto Callegari, Shawn D. Doran, Nicholas J. Grahame, Stafford McLean, Spiros Liras	20
14	Discovery and pharmacological characterization of a selective delta opiate receptor antagonist (CP-646,777) 2011 ·MedChemComm ·Spiros Liras, Stanton F. McHardy, Martin P. Allen, (unknown), Steven D. Heck, Dianne K. Bryce, Anne W. Schmidt, Rebecca E. O’Connor, Michelle Vanase‐Frawley, Ernesto Callegari, Stafford McLean	3
15	Design and Discovery of a Selective Small Molecule κ Opioid Antagonist (2-Methyl-N-((2′-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine, PF-4455242) 2011 ·Journal of Medicinal Chemistry ·Patrick R. Verhoest, (unknown), Vinod D. Parikh, Matthew M. Hayward, Gregory W. Kauffman, (unknown), Stanton F. McHardy, Stafford McLean, Sarah Grimwood, Anne W. Schmidt, Michelle Vanase‐Frawley, (unknown), (unknown), Loretta M. Cox, Diane Wong, Spiros Liras	43
16	Biaryl piperidines as potent and selective delta opioid receptor ligands 2009 ·Bioorganic & Medicinal Chemistry Letters ·Spiros Liras, Stanton F. McHardy, Martin P. Allen, (unknown), Steven D. Heck, Dianne K. Bryce, Anne W. Schmidt, Michelle Vanase‐Frawley, Ernesto Callegari, Stafford McLean	12
17	Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy 2009 ·Journal of Medicinal Chemistry ·Patrick R. Verhoest, (unknown), Michael L. Corman, (unknown), Christopher J. Helal, Xinjun Hou, Robin J. Kleiman, Shenping Liu, Eric S. Marr, Frank S. Menniti, Christopher Schmidt, Michelle Vanase‐Frawley, Anne W. Schmidt, Robert D. Williams, Frederick Nelson, Kari R. Fonseca, Spiros Liras	45
18	Quantitative structure–activity relationship of phenoxyphenyl-methanamine compounds with 5HT2A, SERT, and hERG activities 2008 ·Bioorganic & Medicinal Chemistry Letters ·Scot Mente, Randall J. Gallaschun, Anne W. Schmidt, (unknown), Michelle Vanase‐Frawley, Anton Fliri	7
19	Design, Synthesis, and Evaluation of Metabolism-Based Analogues of Haloperidol Incapable of Forming MPP+-like Species 2003 ·Journal of Medicinal Chemistry ·(unknown), Ramazan Altundaş, Jingbo Xia, (unknown), (unknown), Qi Yang, (unknown), (unknown), (unknown), Anne W. Schmidt, Michelle Vanase‐Frawley, (unknown), (unknown), Ronald F. Borne, Seth Y. Ablordeppey	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact